AIMS: This study is designed to assess the protective cardiac effects after myocardial infarction (MI) of (i) cardiovascular progenitor cells (PC) differentiated directly into cardiomyocytes (CM) and endothelial cells (ECs) at the injury site, as separable from the effects of (ii) paracrine factors released from PC. RESULTS: In vivo: bi-cell patch containing induced pluripotent stem cell (iPSC)-derived CM and EC (BIC) was transplanted onto the infarcted heart. BIC were transduced with herpes simplex virus thymidine kinase "suicide" gene driven by cardiac NCX1 or endothelial vascular endothelium-cadherin promoter. IGF-1α and VEGF levels released from ischemic tissues were significantly enhanced in the BIC patch treatment group. Heart function, infarction size, and vessel density were significantly improved after BIC patch treatment. These effects were completely abolished in the group given ganciclovir (GCV) at week 1 as a suicide gene activator, and partially abolished in the group given GCV at week 3 as compared with the untreated cell patch group. INNOVATION: This study was designed to distinguish between cell-based and noncell-based therapeutic effects of PC lineages after MI. PCs derived from iPSC were genetically modified to express "suicide" gene. iPSC-derived CM and EC were then ablated in situ at week 1 and 3 by intraperitoneal administration of GCV. This enabled direct assessment of the effects of iPSC transplantation on myocardial function and tissue regeneration potential. CONCLUSIONS: Data support a mechanism in which iPSC-derived cardiovascular lineages contribute directly to improved cardiac performance and attenuated remodeling. Paracrine factors provide additional support to the restoration of heart function.
AIMS: This study is designed to assess the protective cardiac effects after myocardial infarction (MI) of (i) cardiovascular progenitor cells (PC) differentiated directly into cardiomyocytes (CM) and endothelial cells (ECs) at the injury site, as separable from the effects of (ii) paracrine factors released from PC. RESULTS: In vivo: bi-cell patch containing induced pluripotent stem cell (iPSC)-derived CM and EC (BIC) was transplanted onto the infarcted heart. BIC were transduced with herpes simplex virus thymidine kinase "suicide" gene driven by cardiac NCX1 or endothelial vascular endothelium-cadherin promoter. IGF-1α and VEGF levels released from ischemic tissues were significantly enhanced in the BIC patch treatment group. Heart function, infarction size, and vessel density were significantly improved after BIC patch treatment. These effects were completely abolished in the group given ganciclovir (GCV) at week 1 as a suicide gene activator, and partially abolished in the group given GCV at week 3 as compared with the untreated cell patch group. INNOVATION: This study was designed to distinguish between cell-based and noncell-based therapeutic effects of PC lineages after MI. PCs derived from iPSC were genetically modified to express "suicide" gene. iPSC-derived CM and EC were then ablated in situ at week 1 and 3 by intraperitoneal administration of GCV. This enabled direct assessment of the effects of iPSC transplantation on myocardial function and tissue regeneration potential. CONCLUSIONS: Data support a mechanism in which iPSC-derived cardiovascular lineages contribute directly to improved cardiac performance and attenuated remodeling. Paracrine factors provide additional support to the restoration of heart function.
Authors: Tiemin Zhao; Dongsheng Zhang; Ronald W Millard; Muhammad Ashraf; Yigang Wang Journal: Am J Physiol Heart Circ Physiol Date: 2009-01-30 Impact factor: 4.733
Authors: Michael E Davis; Patrick C H Hsieh; Tomosaburo Takahashi; Qing Song; Shuguang Zhang; Roger D Kamm; Alan J Grodzinsky; Piero Anversa; Richard T Lee Journal: Proc Natl Acad Sci U S A Date: 2006-05-12 Impact factor: 11.205
Authors: Daniela Tirziu; Emmanuel Chorianopoulos; Karen L Moodie; Robert T Palac; Zhen W Zhuang; Marc Tjwa; Carmen Roncal; Ulf Eriksson; Qiangwei Fu; Arye Elfenbein; Amy E Hall; Peter Carmeliet; Lieve Moons; Michael Simons Journal: J Clin Invest Date: 2007-11 Impact factor: 14.808
Authors: Eleni Tseliou; Geoffrey de Couto; John Terrovitis; Baiming Sun; Liu Weixin; Linda Marbán; Eduardo Marbán Journal: PLoS One Date: 2014-02-18 Impact factor: 3.240